USPTO serial 79233582
PF 72
Reviewed by CopyMark Law Group
Reg. 5736229Status 707Registered
- Filing date
- Status date
- Registration date
- Apr 30, 2019
- Examiner
- SEVERSON, JUSTIN
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with PF 72?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
John P. McCormick
John P. McCormick Fish & Richardson P.C.P.O. Box 1022Minneapolis, MN 55440-1022United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Drug delivery agents [ consisting of compounds ] that facilitate delivery of a wide range of pharmaceuticals; [ drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; ] [ microspheres used as vehicles to deliver drugs in the nature of pharmaceutical preparations; ] [ pharmaceutical preparations and substances for use in drug delivery in cell and tissue; preparations and substances for facilitating the delivery of pharmaceutical and medicinal preparations and substances, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; drug delivery formulations in the form of tablets, capsules, solutions, suspensions, or pellets with tamper resistant properties which facilitate or allow the delivery of a wide range of pharmaceuticals; peptides for drug delivery, namely, drug delivery agents consisting of peptides attached to drugs that facilitate delivery of pharmaceutical preparations; carriers for drug delivery, namely, drug delivery agent in the form of nanoparticle for transferring siRNA in the cell; drug delivery agents that facilitate the delivery of a wide range of pharmaceuticals; drug delivery agents in the form of dissolvable films and coatings for tablets that facilitate the delivery of pharmaceutical preparations; ] drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals [ ; drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents in the form of dissolvable films that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of dissolvable films that facilitate the delivery of nutritional supplements; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of coatings for tablets that facilitate the delivery of nutritional supplements; drug delivery agents consisting of compounds that facilitate delivery by inhalation of a wide range of pharmaceuticals ] | ACTIVE | — |
| 010 | [ Drug delivery apparatus for medical purposes, namely, using microspheres for embolization; electromagnetic drug delivery apparatus for medical use; drug infusion pump; drug delivery devices; implantable drug delivery pump for use as drug delivery device sold empty; implantable medication infuser for use as drug delivery device sold empty; drug delivery platforms; implantable subcutaneous drug delivery devices sold empty; anaesthetic delivery apparatus; medical drug syringes; medical apparatus for introducing pharmaceutical preparations into the human body; medical apparatus for facilitating the inhalation of pharmaceutical preparations; surgical instruments and apparatus; medical products being medical syringes; implants consisting of artificial materials; orthopedic articles, namely, orthopedic walkers and orthopedic supports ] | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Tgel Bio Co., Ltd.
- Other trademarks owned by Tgel Bio Co., Ltd.
- Other trademarks owned by Tgel Bio Co., Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named PF 72
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 23, 2026 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 23, 2026 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Feb 23, 2026 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| Feb 23, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 30, 2025 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Apr 30, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jun 30, 2020 | INNA | INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE | — |
| Jun 16, 2020 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Mar 13, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 6, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 18, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 18, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 18, 2020 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Oct 16, 2019 | COC. | CORRECTION UNDER SECTION 7 - PROCESSED | — |
| Oct 16, 2019 | PLGL | ASSIGNED TO PARALEGAL | — |
| Sep 25, 2019 | LIME | LIMITATION FROM THE IB EXAMINED AND ENTERED | — |
| Jul 30, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 13, 2019 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Apr 30, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 12, 2019 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Apr 12, 2019 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Apr 4, 2019 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Feb 12, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 12, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 8, 2019 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 23, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 23, 2019 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 23, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 26, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 22, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 21, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 21, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 7, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 21, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 21, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 14, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 12, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 12, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 8, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 8, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 7, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |